2 withdrawn. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Post-Traumatic Stress Disorder: new trials by email Literature Review of Post-Traumatic Stress Disorder trials Research Report on Post-Traumatic Stress Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder Nabiximols, Placebo - Post-Traumatic Stress Disorder | Phase 2 / Phase 3 | Withdrawn | Jazz Pharmaceuticals | 2021-02-01 | 2022-06-03 | |
| Adjunctive Pregnenolone in Post-Traumatic Stress Disorder (PTSD) and Depression in Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans pregnenolone, placebo - Post-traumatic Stress Disorder, Major Depressive Disorder | Phase 2 | Withdrawn | US Department of Veterans Affairs | 2010-01-01 | 2014-10-27 |
Stress Disorders, Post-Traumatic (2) · Depression (1) · Depressive Disorder, Major (1)
Mental Disorders (2) · Stress Disorders, Traumatic (2) · Trauma and Stressor Related Disorders (2) · Behavior (1) · Behavioral Symptoms (1) · Depressive Disorder (1) · Mood Disorders (1)
Pregnenolone (1) · nabiximols (1)
Jazz Pharmaceuticals (1) · US Department of Veterans Affairs (1)
United States (1)